DRIO.NASDAQDariohealth CORP

Form 4: DarioHealth CEO Raphael Erez Acquires 800,000 Shares of Common Stock

Sentiment:

SEC Form 4

📋All filings for Dariohealth CORP
🔒Login to Follow

DarioHealth Corp. CEO Raphael Erez reports the acquisition of 800,000 shares of common stock and indirect beneficial ownership of 37,876 shares held by Dicilyon Consulting and Investment Ltd.

Summary

  • On March 6, 2024, Raphael Erez, CEO of DarioHealth Corp., acquired 800,000 shares of common stock.
  • The shares were acquired at a price of $0.
  • 50% of the acquired shares vest immediately, and the remaining 50% vest in quarterly installments over two years, starting March 31, 2024.
  • Following the transaction, Erez directly owns 1,912,059 shares of DarioHealth Corp.
  • Erez also has indirect beneficial ownership of 37,876 shares held by Dicilyon Consulting and Investment Ltd., over which he possesses voting and dispositive power via a proxy, but disclaims beneficial ownership.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard regulatory filing detailing stock transactions. The CEO's purchase is a positive signal, but the filing itself is factual.

Positives

  • The CEO's acquisition of a significant number of shares could be interpreted as a sign of confidence in the company's future prospects.

Management Comments

  • Mr. Raphael disclaims beneficial ownership of the securities set forth herein.

Industry Context

This filing is a routine disclosure related to insider trading activity. It provides transparency to the market regarding the transactions of company executives.

Stakeholder Impact

  • The CEO's stock purchase could positively influence shareholder sentiment.

Key Dates

DateDescription
03/06/2024Date of transaction: Raphael Erez acquired 800,000 shares of common stock.
03/08/2024Date of signature on the Form 4 filing.
03/31/2024Commencement date for quarterly vesting of 50% of the acquired shares over a two-year period.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.